Kerecis Silicone Fish-Skin Combination for Wound Healing Receives Approval from Palmetto Insurance Group
60% of the Medicare population now has access to Kerecis Shield in private doctors’ clinics
60% of the Medicare population now has access to Kerecis Shield in private doctors’ clinics
Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in
Kerecis welcomes the new draft Local Coverage Determination (LCD) policy recently proposed by seven Medicare
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.
Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.
© 2010-2024 Kerecis. All Rights Reserved